US 11576863
Formulation of an antibody and use thereof
granted A61KA61K9/19A61P
Quick answer
US patent 11576863 (Formulation of an antibody and use thereof) held by Takeda Pharmaceutical Company Limited expires Mon Feb 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Feb 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K9/19, A61P, A61P19/02, A61P29/00